MYC deregulation occurs in a wide variety of cancer types through different mechanisms, such as chromosomal translocations [4,5,6], gene amplifications [7], mutations in MYC itself [8], mutations in its upstream regulators [9], and degradation of ubiquitin ligase-mediators, resulting in increased MYC protein stability [10,11]. The gene discussed is MYC; the disease is cancer.